{"id":"W2892903770","doi":"10.1080/14737140.2018.1528146","title":"Health-related quality of life in cancer patients treated with PD-(L)1 inhibitors: a systematic review","year":2018,"lang":"en","type":"review","venue":"Expert Review of Anticancer Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pembrolizumab; Nivolumab; Atezolizumab; Cancer; Lung cancer; Internal medicine; Quality of life (healthcare); Oncology; Clinical trial; Systematic review; Melanoma; Ipilimumab; Head and neck cancer; MEDLINE; Intensive care medicine; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006270241,0.001201998,0.007199659,0.006131786,0.0004327428,0.002047536,0.001312899,0.001571434,0.004529603],"category_scores_gemma":[0.02824418,0.0007142322,0.004910718,0.008252558,0.0006672868,0.001798619,0.001034703,0.001003482,0.0002770234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002873827,"about_ca_system_score_gemma":0.007761003,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006621243,"about_ca_topic_score_gemma":0.01807664,"domain_scores_codex":[0.9944998,0.001978075,0.001639879,0.000642454,0.001057045,0.0001827452],"domain_scores_gemma":[0.9792309,0.01418666,0.004691828,0.0002147949,0.001471339,0.0002044091],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001185182,0.000007510783,0.0007742438,0.9718682,0.00630051,0.00004435026,0.00007698748,0.0000719171,0.00009218307,0.0001465703,0.001957502,0.01854152],"study_design_scores_gemma":[0.0002431855,0.0001534285,0.005932691,0.9218795,0.05204694,0.000295422,0.0001639866,0.0001004053,0.0001357873,0.0004082515,0.01860423,0.00003617741],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008669103,0.9973403,0.00009662072,0.0005365059,0.0001255436,0.0001616344,0.0006495271,0.000005798227,0.000217137],"genre_scores_gemma":[0.01722908,0.979955,0.0003979006,0.001220269,0.0001809472,0.0005447831,0.0003368377,0.00000456169,0.0001306446],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007199659,"threshold_uncertainty_score":0.03316063,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06345455502091561,"score_gpt":0.4126376919410446,"score_spread":0.349183136920129,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}